U.S.–China Trade Truce Takes Effect: Tariff Cuts Tied to Fentanyl Pledge as Beijing Pauses Rare‑Earth Controls
At 12:01 a.m. EST on November 10, 2025, the White House began implementing a U.S.–China trade arrangement that lowers certain tariff rates and delays a planned hike, while China has suspended newly announced rare‑earth and other strategic export controls and moved to restart some U.S. farm imports—a coordinated de‑escalation with immediate policy and market effects. [1]
Washington’s actions include halving “fentanyl‑related” duties on Chinese goods to 10% and extending a one‑year freeze on the “reciprocal” 10% tariff baseline through November 10, 2026. Beijing, for its part, has suspended a suite of rare‑earth and dual‑use export restrictions and restored U.S. soybean licenses and log imports, moves officials on both sides frame as steps toward stabilizing a fraught economic relationship. [2]
What changed today—and why it matters
- Fentanyl‑related tariffs drop from 20% to 10% on Chinese imports; effective with entries on or after 12:01 a.m. EST, Nov. 10. [3]
- A planned increase in the “reciprocal” China tariff rate is suspended for one year; the 10% rate remains in place until Nov. 10, 2026. [4]
- U.S. extends select Section 301 exclusions and suspends certain export‑control measures tied to Chinese entity affiliates for one year. [5]
- China suspends implementation of several rare‑earth and dual‑use export controls and lifts restrictions affecting U.S. soybeans and logs. [6]
The deal’s backbone: public filings and official readouts
U.S. executive actions
According to administration fact sheets and legal advisories, President Trump signed two executive orders on November 4 to operationalize the package: (1) reducing fentanyl‑related duties from 20% to 10% effective November 10; and (2) suspending, for one year, a scheduled increase in the “reciprocal” tariff baseline, keeping the rate at 10% through November 10, 2026. Trade practitioners note the orders also extend certain Section 301 exclusions and delay enforcement of an “affiliate” rule for listed entities. [7]
Chinese measures
Beijing’s Ministry of Commerce announced on November 7–9 the suspension (through November 10, 2026) of multiple October 9 export‑control notices covering rare‑earth materials, lithium‑battery inputs, super‑hard materials, and related technologies; Chinese outlets and wire services reported additional easing on dual‑use controls. China also restored soybean import licenses for U.S. firms and lifted a log‑import ban effective November 10. [8]
Analysts tracking the deal caution that while U.S. steps are fully specified and time‑bound, some Chinese commitments beyond rare‑earths and ag imports remain partly declaratory and will be judged by follow‑through. [9]
Law‑and‑order link: the fentanyl dimension
U.S. officials have tied tariff relief to Chinese actions against fentanyl precursors. Over the weekend, Reuters reported an unannounced trip by FBI Director Kash Patel to Beijing for discussions on fentanyl and law‑enforcement cooperation—reinforcing the enforcement track alongside trade. [10]
What’s at stake for key sectors
Critical minerals and defense supply chains
Beijing’s year‑long pause on rare‑earth and related controls reduces near‑term supply risk for high‑tech and defense manufacturers, though licensing and compliance scrutiny will persist. [11]
Agriculture
China’s restored soybean licenses for CHS, Louis Dreyfus, and EGT—and log‑import resumption—signal incremental demand recovery for U.S. growers and timber. [12]
Semiconductors and entity controls
U.S. suspension of the “affiliate rule” for one year adds short‑term certainty for multinationals while export‑control enforcement continues on other fronts. [13]
Importers and retailers
The 10% reciprocal baseline staying in place averts a jump to 34% this quarter, but firms must still navigate overlapping tariff regimes (IEEPA duties, Section 301) and a volatile policy horizon. [14]
How solid is the truce? Three pressure points to watch
- Verification of Chinese commitments. Some measures (e.g., rare‑earth control suspensions) are on the record; others (ending retaliation against specific U.S. firms) are less fully documented in Chinese notices. Business advisories urge monitoring for actual licensing outcomes. [15]
- Tariff legality at the Supreme Court. Last week’s oral arguments showed skepticism across the ideological spectrum toward using IEEPA for broad import tariffs. A ruling in 2026 could constrain or unwind elements of the tariff architecture now being adjusted under the deal. [16]
- Linkage to fentanyl enforcement. U.S. reductions are explicitly conditioned on Chinese action against precursor flows; the executive orders retain snap‑back discretion if commitments lag. [17]
| Policy lever | Before Nov. 10, 2025 | As of Nov. 10, 2025 |
|---|---|---|
| “Fentanyl‑related” IEEPA tariff on Chinese goods | 20% | 10% (effective 12:01 a.m. EST) [18] |
| “Reciprocal” China tariff baseline | 10% with scheduled increase pending | 10% locked through Nov. 10, 2026 (hike suspended) [19] |
| Section 301 exclusions | Selected exclusions set to expire Nov. 29, 2025 | Extended to Nov. 10, 2026 [20] |
| Chinese export controls (rare‑earths/strategic inputs) | New Oct. 9 measures announced | Suspended to Nov. 10, 2026 [21] |
| U.S. farm exports (soybeans/logs) | Licenses/restrictions tightened in March | Licenses restored; log ban lifted effective Nov. 10 [22] |
Competing narratives
“The reduced rate of 10% is effective … on or after 12:01 a.m. EST on November 10, 2025,” a trade advisory noted, while emphasizing the President retained authority to modify the orders if China fails to implement its commitments. [23]
China’s commerce ministry said suspensions cover multiple rare‑earth‑related notices and will run through November 10, 2026—moves characterized domestically as safeguarding supply‑chain stability while maintaining export‑control principles. [24]
Analysis: What it means and what comes next
Short‑term détente, conditionality intact
The package averts near‑term tariff escalation and signals tactical cooperation on fentanyl, but embeds snap‑back provisions and one‑year clocks that keep leverage alive on both sides. [25]
Supply‑chain breathing room
Suspending rare‑earth and dual‑use controls removes immediate chokepoints for advanced manufacturing, though firms should plan for licensing volatility and geopolitical risk re‑pricing in 2026. [26]
Legal clouds over tariff architecture
If the Supreme Court limits IEEPA‑based tariffs, future White House trade leverage may shift back toward negotiated instruments, targeted Section 301/232 actions, or new legislation. [27]
Domestic politics and international signaling
For Washington, the move links trade relief to fentanyl enforcement amid bipartisan pressure on China; for Beijing, suspensions project flexibility without abandoning the option to re‑tighten controls. [28]
References
- White House Fact Sheet on U.S.–China trade arrangement and effective dates (published Nov. 1, 2025). [29]
- EY TaxNews and DLA Piper client alerts summarizing the Nov. 4 executive orders and Nov. 10 implementation. [30]
- JD Supra/Kelley Drye analysis confirming the 12:01 a.m. EST effective timing and one‑year suspension of tariff hikes. [31]
- MOFCOM/Xinhua notices via China.org.cn and China Daily documenting suspension of rare‑earth and dual‑use export controls to Nov. 10, 2026. [32]
- Reuters reporting on restored soybean licenses and log‑import ban lift effective Nov. 10; and on FBI Director’s Beijing visit tied to fentanyl cooperation. [33]
- Supreme Court context on IEEPA tariffs (AP explainer; analyses of Nov. 5 arguments). [34]
- China Briefing analysis on areas where PRC commitments remain less explicit than U.S. claims. [35]
Bottom line: Today’s synchronized moves lower near‑term trade frictions and link tariff relief to a high‑salience law‑enforcement objective. But with key provisions expiring in 12 months and the Supreme Court weighing the legal basis for the tariff framework, this détente is best viewed as a pause, not an end state. 🧭⚖️
Comments
0 commentsJoin the discussion below.